Pioneering the Next Era of Cellular Innovation
Hummingbird Biomedical was established with a singular, visionary purpose: to transform clinical outcomes through the power of regenerative medicine. Our history is defined by a commitment to scientific excellence and the development of scalable biotech infrastructure that bridges the gap between laboratory research and global health impact.
We envision a future where chronic diseases are no longer managed, but resolved. By fostering a collaborative ecosystem of startups, researchers, and strategic investors, we are architecting the foundational platform that will power the next generation of cell and gene therapies worldwide.
Corporate Values
- Scientific Integrity & Precision
- Scalable Global Ambition
- Strategic Ecosystem Partnership
Visionary Leadership. Scientific Excellence.
Our platform is driven by a global team of pioneers in regenerative medicine, dedicated to scaling biological innovation for long-term health impact.
Dr. Julian Vance
Dr. Seraphina Kross
David Miller
Chief Executive Officer
Head of Regenerative Research
VP of Strategic Operations
Dr. Kenji Tanaka
Clara Sterling
Dr. Elena Rossi
Chief Scientific Officer
Director of Global Partnerships
Scientific Advisory Chair